SR
Swayampakula Ramakanth HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
107
Avg Return
Past Year
Past Year
34%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
89.9%
Neutral
10.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Technology
Financials
Asset Management
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Technology
Software - Infrastructure
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Upgraded
| $5 |
255%
upside
| 4 | -9.2% |
0
%
| 29 Oct ‘25 6 months ago |
|
|
|
Buy
Maintained
| $22 |
202%
upside
| 2 | +16% |
0
%
| 29 Oct ‘25 6 months ago |
|
|
|
Buy
Assumed
| $3 |
249%
upside
| 1 | -26% |
0
%
| 23 Oct ‘25 6 months ago |
|
|
|
Buy
Reiterated
| $11 |
2,544%
upside
| 1 | -69% |
0
%
| 21 Aug ‘25 8 months ago |
|
|
|
Neutral
Reiterated
| $15 |
582%
upside
| 2 | – |
–
| 14 Aug ‘25 8 months ago |
|
|
|
Buy
Maintained
| $3 |
329%
upside
| 2 | -18% |
0
%
| 12 Aug ‘25 8 months ago |
|
|
|
Buy
Reiterated
| $7 |
322%
upside
| 2 | +94% |
0
%
| 24 Jun ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $0.3600 |
1%
downside
| 2 | +38% |
0
%
| 10 Jun ‘25 10 months ago |
|
|
|
Buy
Reiterated
| – | – | 1 | -36% |
0
%
| 19 May ‘25 11 months ago |
|
|
|
Buy
Reiterated
| $3 |
250%
upside
| 3 | -0.9% |
0
%
| 19 May ‘25 11 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | -94% |
–
| 14 May ‘25 11 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +8.1% |
–
| 14 May ‘25 11 months ago |
|